Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,224 GBX | +0.44% | +8.71% | +15.57% |
09:01am | AstraZeneca's Blood Cancer Combo Extends Progression-free Survival in Late-stage Study | MT |
08:58am | Ipsen: new President for North America | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.49% | 236B | |
+33.25% | 699B | |
+26.09% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+5.24% | 198B | |
-9.98% | 194B | |
-3.69% | 149B | |
-5.59% | 154B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- Scientists Discover Cause Behind Blood Clot Formation After AstraZeneca Vaccine